Ishita Drugs & Industries share news and announcements
BSE: 524400Pharmaceuticals & BiotechnologySmall Cap
Last close ₹70.01down ₹2.74 (3.77%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹72.75.
52-week range of traded prices to 23 Oct 2026
₹66.00Low, 13 Jan 2026₹90.85High, 29 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹21 Cr4,064th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 8 Aug 2026
- 29.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 8 Aug 2026
- 6.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Aug 2026
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day.
- 211
Ishita Drugs & Industries board meetings
115 filed, newest first. Page 2 of 3.
Nov 2022
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Aug 2022
8 Aug · Board meeting
Meeting on 13 Aug 2022: quarterly results
May 2022
24 May · Board meeting
Meeting on 30 May 2022: increase in authorised capital and audited results
Feb 2022
7 Feb · Board meeting
Meeting on 14 Feb 2022: quarterly results
Nov 2021
Oct 2021
27 Oct · Board meeting
Meeting on 2 Nov 2021: quarterly results
Aug 2021
9 Aug · Board meeting
Meeting on 13 Aug 2021: quarterly results
Jun 2021
30 Jun · Board meeting
23 Jun · Board meeting
Meeting on 30 Jun 2021
Jan 2021
28 Jan · Board meeting
Meeting on 4 Feb 2021: quarterly results
Nov 2020
2 Nov · Board meeting
Meeting on 9 Nov 2020: quarterly results
Oct 2020
Aug 2020
27 Aug · Board meeting
Meeting on 31 Aug 20205 Aug · Board meeting
Meeting on 13 Aug 2020: quarterly results
Jul 2020
Jun 2020
23 Jun · Board meeting
Meeting on 30 Jun 2020: audited results
Feb 2020
4 Feb · Board meeting
Meeting on 11 Feb 2020: quarterly results
Nov 2019
4 Nov · Board meeting
Meeting on 12 Nov 2019: quarterly results
Aug 2019
5 Aug · Board meeting
Meeting on 13 Aug 2019: quarterly results
May 2019
23 May · Board meeting
Meeting on 29 May 2019: audited results
Apr 2019
2 Apr · Board meeting
Meeting on 9 Apr 2019